Table 3 Medication adherence and HAPA constructs among patients with type 2 diabetes before and after the intervention
Variable | Group | Baseline mean  ±  SD | 1-month follow-up Mean  ±  SD | 6-month follow-up mean  ±  SD | p valuea |
|---|---|---|---|---|---|
Medication adherence | Intervention | 34.1 ± 20.6 | 80.5 ± 8.4 | 89.1 ± 6.8 | p  < 0.001 |
Control | 37.3 ± 18.5 | 42.2 ± 15.8 | 41.5 ± 13.5 | ||
Intention | Intervention | 72.7 ± 16 | 83.9 ± 11.5 | 95.4 ± 6.9 | p  < 0.001 |
Control | 76.8 ± 15.7 | 76.8 ± 15.5 | 76.3 ± 15.4 | ||
Task self-efficacy | Intervention | 55.3 ± 26.4 | 76.7 ± 17.2 | 86.9 ± 11.7 | p  < 0.001 |
Control | 56.8 ± 23.9 | 58.3 ± 23.1 | 59.1 ± 22.5 | ||
Coping self-efficacy | Intervention | 56.2 ± 28.9 | 79.1 ± 19.4 | 88.8 ± 12.1 | p  < 0.001 |
Control | 55.7 ± 24.8 | 58 ± 23.6 | 58.3 ± 23.1 | ||
Recovery self-efficacy | Intervention | 48.3 ± 30.2 | 65.6 ± 20.8 | 73.5 ± 19.1 | p < 0.001 |
Control | 46.5 ± 30.8 | 46.4 ± 30.7 | 45.3 ± 30.6 | ||
Action planning | Intervention | 46.2 ± 28.7 | 70.8 ± 19.1 | 80 ± 16.7 | p  < 0.001 |
Control | 46.9 ± 29.4 | 46.8 ± 29.4 | 44.8 ± 29.2 | ||
Coping planning | Intervention | 53.9 ± 27.9 | 79.8 ± 16.3 | 87.5 ± 10.9 | p  < 0.001 |
Control | 53.9 ± 26 | 56.9 ± 23.8 | 56.3 ± 23.1 | ||
Barriers to medication adherence | Intervention | 70.5 ± 19.1 | 52.3 ± 17.6 | 41.4 ± 16.2 | p  < 0.001 |
Control | 67.8 ± 16.5 | 68.5 ± 16.1 | 68.6 ± 15.5 | ||
Benefits of medication adherence | Intervention | 60 ± 20.9 | 72.6 ± 16.4 | 79.8 ± 15.1 | p  < 0.001 |
Control | 60.8 ± 17.8 | 62.5 ± 16.5 | 60.1 ± 16.1 | ||
Social support | Intervention | 33.1 ± 16 | 46.8 ± 15.5 | 52.9 ± 14.2 | p  < 0.001 |
Control | 34.4 ± 15.4 | 35.4 ± 14.9 | 35.2 ± 14.9 |